These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24560531)

  • 1. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study).
    de Zélicourt M; de Toffol B; Vespignani H; Laurendeau C; Lévy-Bachelot L; Murat C; Fagnani F
    Seizure; 2014 May; 23(5):349-56. PubMed ID: 24560531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: description according to the 2009 ILAE definition of AED resistance (ESPERA study)].
    Vespignani H; de Zélicourt M; Laurendeau C; Fagnani F; Levy-Bachelot L; Murat C; Kahane P; de Toffol B
    Rev Neurol (Paris); 2014 Feb; 170(2):100-9. PubMed ID: 24439556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESPERA study: applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice.
    de Toffol B; de Zélicourt M; Vespignani H; Fagnani F; Laurendeau C; Lévy-Bachelot L; Murat C; Gasalla T; Arzimanoglou A; Villanueva V
    Epilepsy Behav; 2012 Oct; 25(2):166-9. PubMed ID: 23032124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
    Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
    Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study.
    Villanueva V; Girón JM; Martín J; Hernández-Pastor LJ; Lahuerta J; Doz M; Cuesta M; Lévy-Bachelot L;
    Neurologia; 2013 May; 28(4):195-204. PubMed ID: 22743210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
    Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
    Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
    Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: A 5-year follow-up study.
    Picot MC; Jaussent A; Neveu D; Kahane P; Crespel A; Gelisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Macioce V; Dujols P; Ryvlin P
    Epilepsia; 2016 Oct; 57(10):1669-1679. PubMed ID: 27595433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
    Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?
    Zaccara G; Mula M; Ferrò B; Consoli D; Elia M; Giallonardo AT; Iudice A; La Neve A; Meletti S; Tinuper P; Zummo L; Perucca E
    Epilepsia; 2019 Jan; 60(1):175-183. PubMed ID: 30585315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medicoeconomic assessment of epilepsy surgery in adults with medically intractable partial epilepsy. Three-year outcomes from a multicenter French cohort].
    Picot MC; Jaussent A; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Neveu D; Ryvlin P
    Neurochirurgie; 2008 May; 54(3):484-98. PubMed ID: 18440571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
    Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.
    Mula M; Zaccara G; Galimberti CA; Ferrò B; Canevini MP; Mascia A; Mecarelli O; Michelucci R; Pisani LR; Specchio LM; Striano S; Perucca E
    Epilepsia; 2019 Jun; 60(6):1114-1123. PubMed ID: 30866058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY; Wu N; Boulanger L; Sacco P
    J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
    Lee WC; Hoffmann MS; Arcona S; D'Souza J; Wang Q; Pashos CL
    Clin Ther; 2005 Oct; 27(10):1629-38. PubMed ID: 16330300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure outcome after AED failure in pediatric focal epilepsy: impact of underlying etiology.
    Wirrell EC; Wong-Kisiel LC; Nickels KC
    Epilepsy Behav; 2014 May; 34():20-4. PubMed ID: 24681380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of drug reimbursement as markers of disease for epidemiological and cost analysis: The case of severe epilepsy in France].
    Fagnani F; Vespignani H; Kusnik-Joinville O; Bertrand M; Murat C; Lévy-Bachelot L; Kahane P
    Presse Med; 2013 Sep; 42(9 Pt 1):e285-92. PubMed ID: 23601908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
    Noda AH; Hermsen A; Berkenfeld R; Dennig D; Endrass G; Kaltofen J; Safavi A; Wiehler S; Carl G; Meier U; Elger CE; Menzler K; Knake S; Rosenow F; Strzelczyk A
    Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
    Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
    Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
    Brodie MJ; Kelly K; Stephen LJ
    Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.